Ak. Srivastava et al., Development and evaluation of C-telopeptide enzyme-linked immunoassay for measurement of bone resorption in mouse serum, BONE, 27(4), 2000, pp. 529-533
The mouse is increasingly being used as an animal model for the study of sk
eletal phenotypes in humans, mainly because of the ease of genetic manipula
tion. Biochemical markers of bone metabolism provide a valuable parameter f
or the assessment of skeletal metabolism, In the mouse model, assays for bo
ne formation have been available for a long time; however, little is known
about bone resorption markers. The present study describes the development
of a serum C-telopeptide enzyme-linked immunoassay (ELISA), which measures
degradation products of type I collagen that are generated by osteoclastic
bone resorption, The C-telopeptide ELISA uses affinity-purified antibodies
generated against human sequence DFSFLPQPPQEKAHDGGR, The epitope involves a
n amino acid sequence, which is identical in the mouse and human C-terminal
peptide of type I collagen (alpha 1 chain). Sensitivity of the ELISA used
was <0.1 ng/mL, The average intra- (n = 10) and interassay (n = 8) coeffici
ent of variation for two controls was <12%, The average dilution and spike
recovery rates were 98% and 97%, respectively. Application of the ELISA to
measure C-telopeptide in 3-4-week postovariectomized (ovx) C57BL/6J (B6) mi
ce (n = 9 or 10) showed a 45% higher C-telopeptide concentration than the s
ham-operated mice. Treatment of ovx mice with estradiol (400 mu g/kg body w
eight) or alendronate (1.0 mg/kg body weight) resulted in a 20%-50% decreas
e in C-telopeptide levels compared to the vehicle-treated ovx group. In add
ition, B6 mice fed a calcium-deficient diet (0.01% calcium) showed a 50% hi
gher C-telopeptide concentration compared to the B6 mice receiving a normal
diet (0.6% calcium), In conclusion, the C-telopeptide ELISA exhibited acce
ptable analytical performance and sufficient discriminatory power to show e
xpected directional changes in the rate of bone resorption following ovarie
ctomy, ovx plus estradiol or alendronate treatment, and administration of a
calcium-deficient diet. Therefore, the ELISA developed in this study could
be used for measuring bone resorption in the mouse model, (Bone 27: 529-53
3; 2000) (C) 2000 by Elsevier Science Inc. All rights reserved.